Remmie Health is a digital health technology startup targeting 22+ upper respiratory conditions, causing over 120 million annual visits as the leading reason for ambulatory care, impacting every family 2-9 times a year. Remmie's patient-centric primary care at-home examination devices and deeply-engaging assisted diagnosis empower customers with the convenience of hybrid care for any upper respiratory symptoms, from the comfort of their homes or at points of care. Remmie's team won the Muse Innovation Fellowship, UCLA Knapp Venture Competition, Rice Business Plan Competition, and is a UnitedHealthcare Accelerator powered by Techstars and Plug and Play portfolio company. The company is currently based in Seattle, Los Angeles, and London.